Skip to main content

Find Clinical Trials

Home
Conditions
Myelofibrosis Transformation in Essential Thrombocythemia

Clinical trial condition

Myelofibrosis Transformation in Essential Thrombocythemia

Explore clinical trials studying Myelofibrosis Transformation in Essential Thrombocythemia. Study availability and eligibility vary by location and protocol.

3 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Myelofibrosis Transformation in Essential Thrombocythemia trial results

Recruiting

MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)

NCT07362225

Conditions: Accelerated Phase MPN, Accelerated Phase Myeloproliferative Neoplasm, Agnogenic Myeloid Metaplasia, +78 more
Locations: MPN Research Foundation Chicago, Illinois, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Ruxolitinib Phosphate and Azacytidine in Treating Patients With Myelofibrosis or Myelodysplastic Syndrome/Myeloproliferative Neoplasm

NCT01787487

Conditions: Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +10 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Elotuzumab for the Treatment of JAK2-Mutated Myelofibrosis

NCT04517851

Conditions: Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +9 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details